HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (9) Citing Articles via Google Scholar Google Scholar Articles by Giger, J. M. Articles by Baldwin, K. M. Search for Related Content PubMed PubMed Citation Articles by Giger, J. M. Articles by Baldwin, K. M.

Effect of cyclosporin A treatment on the in vivo regulation of type I MHC gene expression

Department of Physiology and Biophysics, University of California, Irvine, California 92697

Submitted 23 July 2003 ; accepted in final form 18 March 2004

Rat soleus muscle consists predominantly of slow type I fibers. We have shown previously through deletion analysis that the highest level of reporter activity that we measure when injecting type I myosin heavy chain (MHC) promoter (MHC₁)-linked luciferase plasmid into soleus muscles depends on the presence of a 550-bp upstream enhancer (3,450–2,900) region of the promoter. Because the calcineurin-nuclear factor of activated T cells (NFAT) pathway has been implicated in the regulation of the slow muscle gene program, particularly the MHC₁ isoform, and the MHC₁ promoter contains several putative NFAT sites, we examined via deletion and mutation analyses whether this pathway is involved in the regulation of promoter activity in soleus. Nine days of treatment with the calcineurin inhibitor cyclosporin A (CsA) caused a significant decrease in activity of the –3,500- and –3,450-bp promoters compared with vehicle-treated rats. Truncation of the promoter to –2,900 bp or smaller reduced the activity and also eliminated the CsA responsiveness, thus implying that the enhancer region is required for CsA responsiveness. Surprisingly, mutating the two NFAT elements within the enhancer region had no obvious effect on promoter activity. CsA treatment resulted in an increase in the mRNA levels of fast-type IIa and IIx MHC isoforms, but RT-PCR analysis of MHC₁ pre-mRNA and mature mRNA expression in soleus muscles revealed no differences between vehicle- and CsA-treated rats. Although CsA affects the activity of the MHC₁ promoter, it appears that its effect is not through direct binding of NFAT to sites on the promoter.

rat; soleus muscle; reverse transcription polymerase chain reaction; promoter; reporter; myosin heavy chain

This article has been cited by other articles:

				C. E. Pandorf, W. H. Jiang, A. X. Qin, P. W. Bodell, K. M. Baldwin, and F. Haddad Calcineurin plays a modulatory role in loading-induced regulation of type I myosin heavy chain gene expression in slow skeletal muscle Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2009; 297(4): R1037 - R1048. [Abstract] [Full Text] [PDF]

				J. Giger, A. X. Qin, P. W. Bodell, K. M. Baldwin, and F. Haddad Activity of the beta-myosin heavy chain antisense promoter responds to diabetes and hypothyroidism Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3065 - H3071. [Abstract] [Full Text] [PDF]

				Y.-C. Huang, R. G. Dennis, and K. Baar Cultured slow vs. fast skeletal muscle cells differ in physiology and responsiveness to stimulation Am J Physiol Cell Physiol, July 1, 2006; 291(1): C11 - C17. [Abstract] [Full Text] [PDF]

				S. Banzet, N. Koulmann, N. Simler, O. Birot, H. Sanchez, R. Chapot, A. Peinnequin, and X. Bigard Fibre-type specificity of interleukin-6 gene transcription during muscle contraction in rat: association with calcineurin activity J. Physiol., August 1, 2005; 566(3): 839 - 847. [Abstract] [Full Text] [PDF]